{"id":"https://openalex.org/W2076218893","doi":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","title":"Safety, Tolerability, and Effect of Food on the Pharmacokinetics of Iloperidone (HP 873), a Potential Atypical Antipsychotic","display_name":"Safety, Tolerability, and Effect of Food on the Pharmacokinetics of Iloperidone (HP 873), a Potential Atypical Antipsychotic","publication_year":1995,"publication_date":"1995-07-01","ids":{"openalex":"https://openalex.org/W2076218893","doi":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","mag":"2076218893","pmid":"https://pubmed.ncbi.nlm.nih.gov/7560252"},"language":"en","primary_location":{"id":"doi:10.1002/j.1552-4604.1995.tb04112.x","doi":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068909694","display_name":"Stephen M. Sainati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Stephen M. Sainati","raw_affiliation_strings":["Department of Clinical Pharmacology, Hoechst-Roussel Pharmaceuticals, Inc., Somerville, New Jersey 08876-1258, USA","Department of Clinical Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hoechst-Roussel Pharmaceuticals, Inc., Somerville, New Jersey 08876-1258, USA","institution_ids":[]},{"raw_affiliation_string":"Department of Clinical Pharmacology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109468948","display_name":"John W. Hubbard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W. Hubbard","raw_affiliation_strings":["Department of Clinical Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047518215","display_name":"Eric Chi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Chi","raw_affiliation_strings":["The Clinical Research Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Clinical Research Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey","institution_ids":["https://openalex.org/I4405286694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056996317","display_name":"Kenneth Grasing","orcid":"https://orcid.org/0000-0002-6464-5700","observed_orcids":["https://orcid.org/0000-0002-6464-5700"]},"institutions":[{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Grasing","raw_affiliation_strings":["The Clinical Research Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Clinical Research Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey","institution_ids":["https://openalex.org/I4405286694"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063504630","display_name":"Martin Brecher","orcid":"https://orcid.org/0009-0009-2016-7741","observed_orcids":["https://orcid.org/0009-0009-2016-7741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin B. Brecher","raw_affiliation_strings":["Department of Clinical Neuroscience, Hoechst\u2010Roussel Pharmaceuticals, Inc., Somerville, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Hoechst\u2010Roussel Pharmaceuticals, Inc., Somerville, New Jersey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068909694"],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.6296,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.69551308,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"35","issue":"7","first_page":"713","last_page":"720"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2709999978542328,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iloperidone","display_name":"iloperidone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8600000143051147},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8180000185966492},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.8240000009536743},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7049999833106995},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.722000002861023},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7170000076293945},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.859000027179718},{"id":"https://openalex.org/keywords/orthostatic-hypotension","display_name":"orthostatic hypotension","score":0.9169999957084656},{"id":"https://openalex.org/keywords/dizziness","display_name":"dizziness","score":0.878000020980835},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7329999804496765},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.8949999809265137},{"id":"https://openalex.org/keywords/5-ht2-receptor-antagonist","display_name":"5-HT2 receptor antagonist","score":0.9819999933242798}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8591420650482178},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7680552005767822},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.71897953748703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5843719244003296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5016465187072754},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4204810857772827},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.340643048286438},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2870057225227356},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.21641704440116882},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.19906079769134521}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1552-4604.1995.tb04112.x","doi":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1995.tb04112.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:7560252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7560252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1816118286","https://openalex.org/W2003376830","https://openalex.org/W2024189501","https://openalex.org/W2037698344","https://openalex.org/W2045877881","https://openalex.org/W2062592895","https://openalex.org/W2085360366","https://openalex.org/W2280261174","https://openalex.org/W2413334594"],"related_works":["https://openalex.org/W2060003069","https://openalex.org/W2381503211","https://openalex.org/W7117319146","https://openalex.org/W2027910471","https://openalex.org/W2070131710","https://openalex.org/W2050386027","https://openalex.org/W2082069541","https://openalex.org/W2033470362","https://openalex.org/W1622551987","https://openalex.org/W1931124461"],"abstract_inverted_index":{"Iloperidone":[0,57,108],"(HP":[1],"873)":[2],"is":[3,10,141,147,152],"a":[4,14,29,76,113],"D2":[5],"and":[6,26,36,39,48,91,101,159,174],"5-HT2":[7],"receptor-antagonist":[8],"that":[9,135],"under":[11],"development":[12],"as":[13],"potential":[15],"atypical":[16],"antipsychotic":[17],"agent.":[18],"Two":[19],"studies":[20],"on":[21,45],"iloperidone":[22],"evaluated":[23],"its":[24,46],"safety":[25],"tolerability,":[27],"made":[28],"preliminary":[30],"pharmacokinetic":[31,83],"assessment":[32],"of":[33,43,75,116,138,169,176],"single":[34,54,77],"3-":[35,78],"5-mg":[37,80],"doses,":[38],"determined":[40],"the":[41,87,136,144,150,162,172],"effect":[42],"food":[44,123,170],"tolerability":[47],"pharmacokinetics":[49],"in":[50,62],"healthy":[51],"volunteers":[52],"after":[53,73],"3-mg":[55],"doses.":[56],"was":[58,109],"well":[59],"absorbed":[60],"orally":[61],"fasted":[63],"subjects.":[64],"The":[65,82],"Cmax":[66],"occurred":[67],"approximately":[68],"2":[69],"to":[70,96,103,118],"3":[71,90],"hours":[72],"administration":[74],"or":[79,130],"dose.":[81],"parameters":[84],"increased":[85],"with":[86,112,122,154],"dose":[88],"between":[89],"5":[92],"mg":[93],"(from":[94],"2.2":[95],"5.2":[97],"ng/mL":[98],"for":[99,106],"Cmax,":[100],"16":[102],"50":[104],"ng/mL.h":[105],"AUC).":[107],"eliminated":[110],"slowly,":[111],"mean":[114],"t1/2":[115],"13.5":[117],"14.0":[119],"hours.":[120],"Coadministration":[121,168],"did":[124],"not":[125],"significantly":[126],"affect":[127],"AUC,":[128],"tmax,":[129],"Cmax.":[131],"These":[132],"results":[133],"indicate":[134],"rate":[137],"iloperidone's":[139],"absorption":[140],"decreased,":[142],"but":[143],"overall":[145],"bioavailability":[146],"unchanged,":[148],"when":[149],"drug":[151],"taken":[153],"food.":[155],"Orthostatic":[156],"hypotension,":[157],"dizziness,":[158],"somnolence":[160],"were":[161],"most":[163],"commonly":[164],"reported":[165],"adverse":[166],"events.":[167,178],"reduced":[171],"incidence":[173],"severity":[175],"these":[177]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}